J. R. Batchelor

6.7k total citations · 1 hit paper
97 papers, 4.9k citations indexed

About

J. R. Batchelor is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. R. Batchelor has authored 97 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Immunology, 24 papers in Rheumatology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. R. Batchelor's work include T-cell and B-cell Immunology (31 papers), Immunotherapy and Immune Responses (19 papers) and Systemic Lupus Erythematosus Research (19 papers). J. R. Batchelor is often cited by papers focused on T-cell and B-cell Immunology (31 papers), Immunotherapy and Immune Responses (19 papers) and Systemic Lupus Erythematosus Research (19 papers). J. R. Batchelor collaborates with scholars based in United Kingdom, United States and Qatar. J. R. Batchelor's co-authors include Robert I. Lechler, G S Panayi, P H Wooley, John Newsom–Davis, Angela Vincent, D. A. S. Compston, Mark Walport, A.H.L. Fielder, C. M. Black and Giovanna Lombardi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

J. R. Batchelor

95 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

1982 641 citations Robert I. Lechler, J. R. Batchelor The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by J. R. Batchelor

Since Specialization

Citations

This map shows the geographic impact of J. R. Batchelor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. R. Batchelor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. R. Batchelor more than expected).

Fields of papers citing papers by J. R. Batchelor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. R. Batchelor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. R. Batchelor. The network helps show where J. R. Batchelor may publish in the future.

Co-authorship network of co-authors of J. R. Batchelor

This figure shows the co-authorship network connecting the top 25 collaborators of J. R. Batchelor. A scholar is included among the top collaborators of J. R. Batchelor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. R. Batchelor. J. R. Batchelor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interferon-α Therapy in HCV Hepatitis: HLA Phenotype and Cirrhosis are Independent Predictors of Clinical Outcome 1998 ·Human Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Mary A. Ritter, J. R. Batchelor	28
2	ASSOCIATION BETWEEN INTERLEUKIN-4-PRODUCING T LYMPHOCYTE FREQUENCIES AND REDUCED RISK OF GRAFT-VERSUS-HOST DISEASE1 1998 ·Transplantation ·Nesrina Imami, Paul Brookes, Giovanna Lombardi, (unknown), Michael Johns, John M. Goldman, J. R. Batchelor, (unknown), M. A. Ritter	19
3	Screening Potential Corneal Donors for HIV-1 by Polymerase Chain Reaction and a Colorimetric Microwell Hybridization Assay 1996 ·American Journal of Ophthalmology ·Lydia R. Essary, (unknown), Ann Butcher, Hong Wang, Keith A. Laycock, Elizabeth Donegan, (unknown), (unknown), J. R. Batchelor, (unknown), Joanne P. Spadoro, Jay S. Pepose	5
4	HLA and hepatitis B infection 1994 ·The Lancet ·(unknown), J. R. Batchelor	104
5	T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. 1993 ·PubMed ·Michel Y. Braun, (unknown), Ginette R. Webb, J. R. Batchelor	4
6	Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance 1993 ·European Journal of Immunology ·Michel Y. Braun, (unknown), (unknown), J. R. Batchelor	26
7	Lymphocytes from multi‐transfused patients exhibit cytotoxicity against autologous cells 1992 ·British Journal of Haematology ·É. Kaminski, Jill Hows, John M. Goldman, J. R. Batchelor	15
8	Structural analysis of human anti-mouse H-2E xenorecognition: T cell receptor bias and impaired CD4 interaction contribute to weak xenoresponses 1992 ·International Immunology ·(unknown), L D Barber, J. R. Batchelor, Robert I. Lechler	7
9	Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or -DQ? 1991 ·Human Immunology ·D. A. Francis, Alan J. Thompson, Paul Brookes, N. J. Davey, Robert I. Lechler, W. I. McDonald, J. R. Batchelor	47
10	Individual variation in alloresponsiveness and the molecular basis of allorecognition 1990 ·Human Immunology ·J. R. Batchelor, É. Kaminski, Giovanna Lombardi, J M Goldman, Robert I. Lechler	3
11	Individual variation in the frequency of HLA class II‐specific cytotoxic T lymphocyte precursors 1990 ·European Journal of Immunology ·Stephen Man, Robert I. Lechler, J. R. Batchelor, C. Sharrock	16
12	HLA class III haplotypes in multicase rheumatoid arthritis families 1989 ·Human Immunology ·A.H.L. Fielder, William Ollier, (unknown), Mari‐Wyn Burley, A J Silman, J. Awad, H. Festenstein, J. R. Batchelor	12
13	An allelic cluster of DQα restriction fragments is associated with multiple sclerosis: Evidence that a second haplotype may influence disease susceptibility 1989 ·Human Immunology ·Robert Heard, (unknown), Derek Middleton, Stanley Hawkins, D A Francis, Jaclyn Hern, W. I. McDonald, J. R. Batchelor, Robert I. Lechler	27
14	Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. 1983 ·BMJ ·A.H.L. Fielder, Mark Walport, J. R. Batchelor, Richard I. Rynes, C. M. Black, I. Anthony Dodi, G. R. V. Hughes	363
15	Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. breakdown → 1982 ·The Journal of Experimental Medicine ·Robert I. Lechler, J. R. Batchelor	641
16	An immunogenetic basis for the tissue involvement in Behçet's syndrome. 1979 ·PubMed ·Thomas Lehner, J. R. Batchelor, Stephen Challacombe, (unknown)	43
17	Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. 1978 ·BMJ ·G S Panayi, P H Wooley, J. R. Batchelor	241
18	Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. 1976 ·BMJ ·R.J. Bailey, N Krasner, A L Eddleston, Roger Williams, D. E. H. Tee, Deborah Doniach, L. Kennedy, J. R. Batchelor	95
19	Histocompatibility Antigens in Active Chronic Hepatitis and Primary Biliary Cirrhosis 1974 ·BMJ ·Robert M. Galbraith, A L Eddleston, M. G. M. Smith, Roger Williams, (unknown), G Watkinson, H. Dick, L. Kennedy, J. R. Batchelor	84
20	Conceptual Advances in Immunology and Oncology 1965 ·Immunology ·J. R. Batchelor	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact